Pelliciari, Davy Henrique Sousa, et al. “Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? – a Pharmacoeconomic Study”. Headache Medicine, vol. 15, no. Supplement, Aug. 2024, p. 98, https://www.headachemedicine.com.br/index.php/hm/article/view/1230.